Review





Similar Products

3d accelerometer sensor ax3  (Axivity Ltd)
90
Axivity Ltd 3d accelerometer sensor ax3

3d Accelerometer Sensor Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/3d accelerometer sensor ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
3d accelerometer sensor ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
acc sensor axivity ax3  (Axivity Ltd)
90
Axivity Ltd acc sensor axivity ax3
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Acc Sensor Axivity Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/acc sensor axivity ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
acc sensor axivity ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
light sensors ax3  (Axivity Ltd)
90
Axivity Ltd light sensors ax3
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Light Sensors Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/light sensors ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
light sensors ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
light sensors axivity ax3  (Axivity Ltd)
90
Axivity Ltd light sensors axivity ax3
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Light Sensors Axivity Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/light sensors axivity ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
light sensors axivity ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ax3 sensor  (Axivity Ltd)
90
Axivity Ltd ax3 sensor
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Ax3 Sensor, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ax3 sensor/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
ax3 sensor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
motion sensor axivity ax3  (Axivity Ltd)
90
Axivity Ltd motion sensor axivity ax3
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Motion Sensor Axivity Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/motion sensor axivity ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
motion sensor axivity ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
motion sensor axivity ax3 monitor  (Axivity Ltd)
90
Axivity Ltd motion sensor axivity ax3 monitor
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Motion Sensor Axivity Ax3 Monitor, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/motion sensor axivity ax3 monitor/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
motion sensor axivity ax3 monitor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
motion sensors axivity ax3 monitor  (Axivity Ltd)
90
Axivity Ltd motion sensors axivity ax3 monitor
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Motion Sensors Axivity Ax3 Monitor, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/motion sensors axivity ax3 monitor/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
motion sensors axivity ax3 monitor - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wearable imu-based sensor axivity ax3  (Axivity Ltd)
90
Axivity Ltd wearable imu-based sensor axivity ax3
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Wearable Imu Based Sensor Axivity Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wearable imu-based sensor axivity ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
wearable imu-based sensor axivity ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
wrist-worn sensors ax3  (Axivity Ltd)
90
Axivity Ltd wrist-worn sensors ax3
Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, <t>ACC,</t> and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, <t>and</t> <t>biomarker</t> datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .
Wrist Worn Sensors Ax3, supplied by Axivity Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/wrist-worn sensors ax3/product/Axivity Ltd
Average 90 stars, based on 1 article reviews
wrist-worn sensors ax3 - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


Journal: Data in Brief

Article Title: ActBeCalf: Accelerometer-based multivariate time-series dataset for calf behavior classification

doi: 10.1016/j.dib.2025.111462

Figure Lengend Snippet:

Article Snippet: Data collection , This experiment involved 30 Holstein Friesian and Jersey pre-weaned calves housed in 4 group pens. Each calf was equipped with a 3D accelerometer sensor (AX3, Axivity Ltd, Newcastle, UK; 11g) sampled at 25 Hz and attached to a neck collar from 1 week of birth over 13 weeks. The sensors were removed bi-weekly to recharge the batteries and extract the data. An 8Mp Dome3 CCTV camera was fixed high up in each pen. Behaviors were manually annotated from the videos using the Behavioral Observation Research Interactive Software based on an ethogram (23 behaviors). After timestamp synchronization, observations and accelerometer time-series were aligned using Python (v3.9). No normalization has been applied to the accelerometer time-series..

Techniques: Software

Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, ACC, and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, and biomarker datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .

Journal: Journal of Alzheimer's Disease Reports

Article Title: An experimental framework for conjoint measures of olfaction, navigation, and motion as pre-clinical biomarkers of Alzheimer's disease

doi: 10.1177/25424823241307617

Figure Lengend Snippet: Proposed practical application of the experimental framework for conjoint study of olfactory and spatial disorders. Self-use of commercially available and affordable OI, ACC, and GPS tests facilitates broad, cross-cultural data collection. An AI-driven analytic tool cross-references the data with OI, gait speed, navigation patterns, and biomarker datasets in a privacy-protective manner, indicating potential AD risk. Non-invasive blood-based biomarkers can further strengthen the preclinical indications. Focusing costly, invasive clinical biomarker testing and prospective treatment administration on at-risk candidates could reduce economic costs and improve patients’ quality of life. The early AD diagnosis could prepare patients and their carers for the disease course. ACC: accelerometry; AD: Alzheimer's disease; AI: artificial intelligence; BSIT ® : Brief Smell Identification Test ® ; GPS: Global Positioning System; UPSIT ® : University of Pennsylvania Smell Identification Test TM .

Article Snippet: A study of sleep behavior disorder as a Parkinson's disease biomarker monitored gait continuously with a validated ACC sensor (Axivity AX3).

Techniques: Biomarker Discovery